Gavazza A - Search Results

1

A vaccine targeting telomerase enhances survival of dogs affected by B-cell lymphoma.

Peruzzi D, Gavazza A, Mesiti G, Lubas G, Scarselli E, Conforti A, Bendtsen C, Ciliberto G, La Monica N, Aurisicchio L. Peruzzi D, et al. Among authors: gavazza a. Mol Ther. 2010 Aug;18(8):1559-67. doi: 10.1038/mt.2010.104. Epub 2010 Jun 8. Mol Ther. 2010. PMID: 20531395 Free PMC article.

2

Safety and efficacy of a genetic vaccine targeting telomerase plus chemotherapy for the therapy of canine B-cell lymphoma.

Gavazza A, Lubas G, Fridman A, Peruzzi D, Impellizeri JA, Luberto L, Marra E, Roscilli G, Ciliberto G, Aurisicchio L. Gavazza A, et al. Hum Gene Ther. 2013 Aug;24(8):728-38. doi: 10.1089/hum.2013.112. Hum Gene Ther. 2013. PMID: 23902422 Free PMC article. Clinical Trial.

3

Tel-eVax: a genetic vaccine targeting telomerase for treatment of canine lymphoma.

Impellizeri JA, Gavazza A, Greissworth E, Crispo A, Montella M, Ciliberto G, Lubas G, Aurisicchio L. Impellizeri JA, et al. Among authors: gavazza a. J Transl Med. 2018 Dec 11;16(1):349. doi: 10.1186/s12967-018-1738-6. J Transl Med. 2018. PMID: 30537967 Free PMC article.

4

Faecal microbiota in dogs with multicentric lymphoma.

Gavazza A, Rossi G, Lubas G, Cerquetella M, Minamoto Y, Suchodolski JS. Gavazza A, et al. Vet Comp Oncol. 2018 Mar;16(1):E169-E175. doi: 10.1111/vco.12367. Epub 2017 Nov 20. Vet Comp Oncol. 2018. PMID: 29152844

5

A case report of T-cell lymphoma in a horse.

Gavazza A, Lubas G, Turinelli V, Ghernati I, Delgadillo AJ. Gavazza A, et al. Vet Res Commun. 2003 Sep;27 Suppl 1:403-5. doi: 10.1023/b:verc.0000014190.79892.58. Vet Res Commun. 2003. PMID: 14535440 No abstract available.

6

Estimated prevalence of canine Type 2 Von Willebrand disease in the Deutsch-Drahthaar (German Wirehaired Pointer) in Europe.

Gavazza A, Presciuttini S, Keuper H, Lubas G. Gavazza A, et al. Res Vet Sci. 2012 Dec;93(3):1462-6. doi: 10.1016/j.rvsc.2012.06.010. Epub 2012 Jul 21. Res Vet Sci. 2012. PMID: 22824509

7

Hematological, Biochemical, and Serological Findings in Healthy Canine Blood Donors after the Administration of CaniLeish® Vaccine.

Starita C, Gavazza A, Lubas G. Starita C, et al. Among authors: gavazza a. Vet Med Int. 2016;2016:4601893. doi: 10.1155/2016/4601893. Epub 2016 May 22. Vet Med Int. 2016. PMID: 27313949 Free PMC article.

8

Prevalence of Dog Erythrocyte Antigen 1 in 7,414 Dogs in Italy.

Medina Valentin AA, Gavazza A, Lubas G. Medina Valentin AA, et al. Among authors: gavazza a. Vet Med Int. 2017;2017:5914629. doi: 10.1155/2017/5914629. Epub 2017 Sep 24. Vet Med Int. 2017. PMID: 29147599 Free PMC article.

9

Use of totally implantable vascular access port with mini-invasive Seldinger technique in 12 dogs undergoing chemotherapy.

Valentini F, Fassone F, Pozzebon A, Gavazza A, Lubas G. Valentini F, et al. Among authors: gavazza a. Res Vet Sci. 2013 Feb;94(1):152-7. doi: 10.1016/j.rvsc.2012.07.023. Epub 2012 Aug 22. Res Vet Sci. 2013. PMID: 22921371

10

Association between canine malignant lymphoma, living in industrial areas, and use of chemicals by dog owners.

Gavazza A, Presciuttini S, Barale R, Lubas G, Gugliucci B. Gavazza A, et al. J Vet Intern Med. 2001 May-Jun;15(3):190-5. J Vet Intern Med. 2001. PMID: 11380026 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

50 results

Search Page